211 related articles for article (PubMed ID: 29723928)
1. Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants.
Saiz-Rodríguez M; Belmonte C; Román M; Ochoa D; Jiang-Zheng C; Koller D; Mejía G; Zubiaur P; Wojnicz A; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2018 Oct; 123(4):474-485. PubMed ID: 29723928
[TBL] [Abstract][Full Text] [Related]
2. Influence of CYP2D6, CYP3A4, CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers.
Belmonte C; Ochoa D; Román M; Saiz-Rodríguez M; Wojnicz A; Gómez-Sánchez CI; Martín-Vílchez S; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2018 Jun; 122(6):596-605. PubMed ID: 29325225
[TBL] [Abstract][Full Text] [Related]
3. Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects.
Koller D; Belmonte C; Lubomirov R; Saiz-Rodríguez M; Zubiaur P; Román M; Ochoa D; Carcas A; Wojnicz A; Abad-Santos F
J Psychopharmacol; 2018 Nov; 32(11):1212-1222. PubMed ID: 30251598
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics.
Saiz-Rodríguez M; Ochoa D; Belmonte C; Román M; Vieira de Lara D; Zubiaur P; Koller D; Mejía G; Abad-Santos F
J Psychopharmacol; 2019 Apr; 33(4):522-531. PubMed ID: 30789308
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment.
Shilbayeh SA; Sy SK; Melhem M; Zmeili R; Derendorf H
Clin Pharmacol Drug Dev; 2015 Sep; 4(5):387-94. PubMed ID: 27137148
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects.
Saiz-Rodríguez M; Ochoa D; Herrador C; Belmonte C; Román M; Alday E; Koller D; Zubiaur P; Mejía G; Hernández-Martínez M; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):321-329. PubMed ID: 30281924
[TBL] [Abstract][Full Text] [Related]
7. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
BMC Psychiatry; 2018 Jul; 18(1):231. PubMed ID: 30016952
[TBL] [Abstract][Full Text] [Related]
8. Influence of ABCB1 and CYP3A5 genetic polymorphisms on the pharmacokinetics of quetiapine in healthy volunteers.
Kim KA; Joo HJ; Lee HM; Park JY
Pharmacogenet Genomics; 2014 Jan; 24(1):35-42. PubMed ID: 24240480
[TBL] [Abstract][Full Text] [Related]
9. Interindividual variability in dabigatran and rivaroxaban exposure: contribution of ABCB1 genetic polymorphisms and interaction with clarithromycin.
Gouin-Thibault I; Delavenne X; Blanchard A; Siguret V; Salem JE; Narjoz C; Gaussem P; Beaune P; Funck-Brentano C; Azizi M; Mismetti P; Loriot MA
J Thromb Haemost; 2017 Feb; 15(2):273-283. PubMed ID: 27893182
[TBL] [Abstract][Full Text] [Related]
10. The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone.
Jovanović N; Božina N; Lovrić M; Medved V; Jakovljević M; Peleš AM
Eur J Clin Pharmacol; 2010 Nov; 66(11):1109-17. PubMed ID: 20563569
[TBL] [Abstract][Full Text] [Related]
11. Influence of Genetic Polymorphisms on the Pharmacokinetics of Trazodone Hydrochloride: A Scoping Review and Future Perspective.
Meulman J; Visacri MB; Moriel P; Pincinato EC
Ther Drug Monit; 2023 Aug; 45(4):479-486. PubMed ID: 36191287
[TBL] [Abstract][Full Text] [Related]
12. Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers.
Saiz-Rodríguez M; Belmonte C; Román M; Ochoa D; Koller D; Talegón M; Ovejero-Benito MC; López-Rodríguez R; Cabaleiro T; Abad-Santos F
Basic Clin Pharmacol Toxicol; 2018 May; 122(5):501-511. PubMed ID: 29136336
[TBL] [Abstract][Full Text] [Related]
13. ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population.
Ozbey G; Yucel B; Taycan SE; Kan D; Bodur NE; Arslan T; Percin F; Yuksel N; Guzey C; Uluoglu C
Pharmacol Rep; 2014 Apr; 66(2):235-8. PubMed ID: 24911075
[TBL] [Abstract][Full Text] [Related]
14. The predictive value of ABCB1, ABCG2, CYP3A4/5 and CYP2D6 polymorphisms for risperidone and aripiprazole plasma concentrations and the occurrence of adverse drug reactions.
Rafaniello C; Sessa M; Bernardi FF; Pozzi M; Cheli S; Cattaneo D; Baldelli S; Molteni M; Bernardini R; Rossi F; Clementi E; Bravaccio C; Radice S; Capuano A
Pharmacogenomics J; 2018 May; 18(3):422-430. PubMed ID: 28719598
[TBL] [Abstract][Full Text] [Related]
15. The effects of aripiprazole and olanzapine on pupillary light reflex and its relationship with pharmacogenetics in a randomized multiple-dose trial.
Koller D; Saiz-Rodríguez M; Zubiaur P; Ochoa D; Almenara S; Román M; Romero-Palacián D; de Miguel-Cáceres A; Martín S; Navares-Gómez M; Mejía G; Wojnicz A; Abad-Santos F
Br J Clin Pharmacol; 2020 Oct; 86(10):2051-2062. PubMed ID: 32250470
[TBL] [Abstract][Full Text] [Related]
16. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers.
Zubiaur P; Soria-Chacartegui P; Koller D; Navares-Gómez M; Ochoa D; Almenara S; Saiz-Rodríguez M; Mejía-Abril G; Villapalos-García G; Román M; Martín-Vílchez S; Abad-Santos F
Biomed Pharmacother; 2021 Jan; 133():111087. PubMed ID: 33378980
[TBL] [Abstract][Full Text] [Related]
17.
Santos M; Lima L; Carvalho S; Brandão A; Barroso F; Cruz A; Medeiros R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791151
[TBL] [Abstract][Full Text] [Related]
18. Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females.
Rahikainen AL; Palo JU; Haukka J; Sajantila A
Pharmacogenet Genomics; 2018 Apr; 28(4):99-106. PubMed ID: 29481489
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics of trazodone in healthy volunteers: association with pharmacokinetics, pharmacodynamics and safety.
Saiz-Rodríguez M; Belmonte C; Derqui-Fernández N; Cabaleiro T; Román M; Ochoa D; Talegón M; Ovejero-Benito MC; Abad-Santos F
Pharmacogenomics; 2017 Nov; 18(16):1491-1502. PubMed ID: 29061081
[TBL] [Abstract][Full Text] [Related]
20.
Gao YL; He B
DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]